Guru Ownership Trend
Guru Analysis for ArriVent BioPharma, Inc. (AVBP)
ArriVent BioPharma, Inc. (AVBP), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.45 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.42 M net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Cliff Asness reduced exposure by 2.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for ArriVent BioPharma, Inc. (AVBP)
Major holders include Steven Cohen ($4.36 M), Cliff Asness ($230,878). According to the latest reported data, 2 tracked investment managers collectively hold approximately 228,135 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.42 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited AVBP. The total reported sell value was $7.78 M.
Yes, 1 managers opened new positions in AVBP, and 0 increased their existing holdings. The total reported buy value was $4.36 M.